文献速递创伤与烧伤复苏、休克与脓毒症

自膨胀泡沫与腹膜前填塞治疗骨盆大出血的比较

Self-expanding foam versus preperitoneal packing for exsanguinating pelvic hemorrhage.
PubMed 文献 · J Trauma Acute Care Surg · 2023-09-13
一句话结论猪模型显示,经皮注射ResQFoam至腹膜前间隙可改善骨盆大出血生存,效果与标准腹膜前填塞相当。

该研究建立两种非凝血障碍猪骨盆出血模型(有无骨盆骨折),评估ResQFoam与腹膜前填塞的疗效。模型1(无骨折)中仅ResQFoam显著改善生存(中位生存67分钟 vs 对照6分钟,p=0.057),且出血量显著少于对照(21.5±5.3 g/kg vs 31.6±5.0 g/kg,p<0.001)和腹膜前填塞(32.7±5.4 g/kg,p<0.001)。模型2(伴复杂骨盆骨折)中ResQFoam和腹膜前填塞均较对照显著改善生存(124分钟和119分钟 vs 4分钟,p=0.013和p=0.004)。结论认为该技术可能扩展骨盆出血的治疗手段。

要点

  • 模型1(无骨盆骨折):ResQFoam组中位生存67分钟 vs 对照6分钟(p=0.057),腹膜前填塞组50分钟 vs 对照6分钟(p=0.002)。
  • 模型1:ResQFoam组出血量21.5±5.3 g/kg,显著低于对照31.6±5.0 g/kg(p<0.001)和腹膜前填塞32.7±5.4 g/kg(p<0.001)。
  • 模型2(伴复杂骨盆骨折):ResQFoam组中位生存124分钟 vs 对照4分钟(p=0.013),腹膜前填塞组119分钟 vs 对照4分钟(p=0.004)。
  • ResQFoam经皮注射至腹膜前间隙,在两种模型中均改善生存,模型2中与标准腹膜前填塞生存获益相似。
  • 该技术可能扩展骨盆出血的治疗工具,但证据来自猪模型,尚需进一步研究。

适用人群与场景

  • 非凝血障碍猪的骨盆出血模型:模型1为双侧闭合腔主要血管腹膜后出血不伴骨盆骨折;模型2为单侧闭合腔腹膜后出血(伴腹腔沟通)合并复杂骨盆骨折。
  • 临床对应人群为骨盆骨折伴失血性休克患者(原文背景提及该人群死亡率21%–57%)。

处置流程与药物剂量

  • 模型1:伤后不予治疗(对照,n=10)、用腹腔垫行腹膜前填塞(n=11)或经皮注射ResQFoam至腹膜前间隙(n=10)。
  • 模型2:伤后给予复苏(对照,n=12)、复苏加腹膜前填塞(n=10)或复苏加经皮注射ResQFoam至腹膜前间隙(n=10)。

研究设计与关键结果

  • 研究类型:动物实验(非凝血障碍猪),建立两种骨盆出血模型,评估ResQFoam与腹膜前填塞的疗效。
  • 模型1:仅ResQFoam提供显著生存获益;中位生存时间腹膜前填塞组50分钟、ResQFoam组67分钟,对照6分钟(p=0.002和p=0.057)。
  • 模型1:ResQFoam组出血量21.5±5.3 g/kg,显著低于对照31.6±5.0 g/kg(p<0.001)和腹膜前填塞32.7±5.4 g/kg(p<0.001);泡沫治疗促进血流动力学稳定。
  • 模型2:ResQFoam和腹膜前填塞均较对照显著改善生存;中位生存时间腹膜前填塞组119分钟、ResQFoam组124分钟,对照4分钟(p=0.004和p=0.013)。

证据类型、等级与局限

  • 证据类型:动物实验(非凝血障碍猪模型)。
  • 局限性:ResQFoam组与对照组生存比较p=0.057(未达统计学显著);结论指出该技术有潜力扩展骨盆出血治疗工具,尚需进一步研究。

对床旁实践的改变

  • 在猪骨盆出血模型中,经皮注射ResQFoam至腹膜前间隙改善生存,模型2中生存获益与标准腹膜前填塞相似;作者认为该技术有潜力扩展骨盆出血的治疗工具。
  • 证据来自动物模型,尚不能直接转化为临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Mortality for pelvic fracture patients presenting with hemorrhagic shock ranges from 21% to 57%. The objective of this study was to develop a lethal and clinically relevant pelvic hemorrhage animal model with and without bony fracture for evaluating therapeutic interventions. ResQFoam is a self-expanding foam that has previously been described to significantly decrease mortality in large-animal models of abdominal exsanguination. We hypothesized that administration of ResQFoam into the preperitoneal space could decrease mortality in exsanguinating pelvic hemorrhage.

METHODS: Two pelvic hemorrhage models were developed using noncoagulopathic swine. Pelvic hemorrhage model 1: bilateral, closed-cavity, major vascular retroperitoneal hemorrhage without bony pelvic fracture. After injury, animals received no treatment (control, n = 10), underwent preperitoneal packing using laparotomy pads (n = 11), or received ResQFoam (n = 10) injected into the preperitoneal space. Pelvic hemorrhage model 2: unilateral, closed-cavity, retroperitoneal hemorrhage injury (with intraperitoneal communication) combined with complex pelvic fracture. After injury, animals received resuscitation (control, n = 12), resuscitation with preperitoneal packing (n = 10) or with ResQFoam injection (n = 10) into the preperitoneal space.

RESULTS: For model 1, only ResQFoam provided a significant survival benefit. The median survival times were 50 minutes and 67 minutes for preperitoneal packing and ResQFoam, compared with 6 minutes with controls ( p = 0.002 and 0.057, respectively). Foam treatment facilitated hemodynamic stabilization and resulted in significantly less hemorrhage (21.5 ± 5.3 g/kg) relative to controls (31.6 ± 5.0 g/kg, p < 0.001) and preperitoneal packing (32.7 ± 5.4 g/kg, p < 0.001). For model 2, both ResQFoam and preperitoneal packing resulted in significant survival benefit compared with controls. The median survival times were 119 minutes and 124 minutes for the preperitoneal packing and ResQFoam groups, compared with 4 minutes with controls ( p = 0.004 and 0.013, respectively).

CONCLUSION: Percutaneous injection of ResQFoam into the preperitoneal space improved survival relative to controls, and similar survival benefit was achieved compared with standard preperitoneal pelvic packing. The technology has potential to augment the armamentarium of tools to treat pelvic hemorrhage.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. King DR, Hwabejire JO, Pham QP, et al. Self-expanding foam versus preperitoneal packing for exsanguinating pelvic hemorrhage. J Trauma Acute Care Surg. 2023. PMID: 37700445. doi:10.1097/TA.0000000000004138

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。